NFATc1 and NFATc2 repress spontaneous osteoarthritis.

TitleNFATc1 and NFATc2 repress spontaneous osteoarthritis.
Publication TypeJournal Article
Year of Publication2013
AuthorsGreenblatt MB, Ritter SY, Wright J, Tsang K, Hu D, Glimcher LH, Aliprantis AO
JournalProc Natl Acad Sci U S A
Volume110
Issue49
Pagination19914-9
Date Published2013 Dec 03
ISSN1091-6490
KeywordsAnimals, Cartilage, Articular, Chondrocytes, Gene Expression Regulation, Immunohistochemistry, Mice, Mice, Knockout, Models, Biological, NFATC Transcription Factors, Osteoarthritis, Real-Time Polymerase Chain Reaction, X-Ray Microtomography
Abstract

Osteoarthritis (OA) was once viewed originally as a mechanical disease of "wear and tear," but advances made during the past two decades suggest that abnormal biomechanics contribute to active dysregulation of chondrocyte biology, leading to catabolism of the cartilage matrix. A number of signaling and transcriptional mechanisms have been studied in relation to the regulation of this catabolic program, but how they specifically regulate the initiation or progression of the disease is poorly understood. Here, we demonstrate that cartilage-specific ablation of Nuclear factor of activated T cells c1 (Nfatc1) in Nfatc2(-/-) mice leads to early onset, aggressive OA affecting multiple joints. This model recapitulates features of human OA, including loss of proteoglycans, collagen and aggrecan degradation, osteophyte formation, changes to subchondral bone architecture, and eventual progression to cartilage effacement and joint instability. Consistent with the notion that NFATC1 is an OA-suppressor gene, NFATC1 expression was significantly down-regulated in paired lesional vs. macroscopically normal cartilage samples from OA patients. The highly penetrant, early onset, and severe nature of this model make it an attractive platform for the preclinical development of treatments to alter the course of OA. Furthermore, these findings indicate that NFATs are key suppressors of OA, and regulating NFATs or their transcriptional targets in chondrocytes may lead to novel disease-modifying OA therapies.

DOI10.1073/pnas.1320036110
Alternate JournalProc Natl Acad Sci U S A
PubMed ID24248346
Grant ListR01AR060363-01 / AR / NIAMS NIH HHS / United States
K08AR054859 / AR / NIAMS NIH HHS / United States
Related Faculty: 
Matthew B. Greenblatt, M.D., Ph.D.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700